Charles Guenancia
Overview
Explore the profile of Charles Guenancia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
110
Citations
1013
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Guilleminot P, Mourot M, Lorgis L, Didier R, Ferrand B, Laurent G, et al.
Catheter Cardiovasc Interv
. 2025 Mar;
PMID: 40038892
Background: In selected patient populations, percutaneous closure of patent foramen ovale has been shown to be beneficial in preventing cerebral ischaemic events. In most cases, this procedure requires echocardiographic guidance,...
3.
Guenancia C, Lequeux B, Amara W, Buiciuc O, Damy T, Defaye P, et al.
JACC Adv
. 2025 Feb;
4(3):101604.
PMID: 39954342
Background: Cardiac amyloidosis (CA) is an increasingly recognized cardiomyopathy with an associated risk of arrhythmias and conduction disorders; however, managing arrhythmias and conductive disorders remains largely undefined. Objectives: This study...
4.
Houbachi L, Walker P, Fournel I, Ksiazek E, Petit J, Cochet A, et al.
Diabetes Res Clin Pract
. 2025 Feb;
221:112017.
PMID: 39900263
Background: We hypothesized that the reduction of intramyocardial fat content may be involved in the cardioprotective effect of glucagon-like peptide-1 receptor agonists (GLP1-RA) in patients with type 2 diabetes (T2D)....
5.
Lellouche N, Defaye P, Algalarrondo V, Gandjbakhch E, Fauchier L, Champ-Rigot L, et al.
Arch Cardiovasc Dis
. 2024 Nov;
118(1):63-74.
PMID: 39613699
No abstract available.
6.
Bamde C, Blitti C, Bar G, Die Loucou J, Laubriet A, Guenancia C, et al.
Ann Vasc Surg
. 2024 Oct;
110(Pt B):434-439.
PMID: 39419323
Background: The common femoral artery is the most commonly used vascular access due to its low complication rate and high technical success rate. However, this approach may be less suitable...
7.
Bamde C, Goueffic Y, Blitti C, Die Loucou J, Lalande A, Laubriet-Jazayeri A, et al.
J Vasc Surg
. 2024 Sep;
81(2):397-407.
PMID: 39321897
Background: Endovascular treatment of the common femoral artery (CFA) and its bifurcation is currently recommended for patients with hostile groin (prior femoral bifurcation open surgery, history of radiotherapy) or severe...
8.
Echivard M, Sellal J, Ziliox C, Marijon E, Bordachar P, Ploux S, et al.
Eur Heart J
. 2024 Sep;
45(41):4428-4442.
PMID: 39299922
Background And Aims: Prophylactic implantable cardioverter-defibrillators (ICDs) are not recommended until left ventricular ejection fraction (LVEF) has been reassessed 40 to 90 days after an acute myocardial infarction. In the...
9.
Benali K, Duloquin G, Noto-Campanella C, Garnier L, Didier R, Pommier T, et al.
Arch Cardiovasc Dis
. 2024 Sep;
117(11):616-623.
PMID: 39232887
Background: Although guidelines recommend screening patients for atrial fibrillation (AF) after stroke, the optimal timing and combination of screening tools remain unclear. Aims: We evaluated the suitability of a sequential...
10.
Guenancia C, Bejot Y
J Am Heart Assoc
. 2024 Aug;
13(17):e036138.
PMID: 39190602
No abstract available.